Artificial intelligence is significantly transforming the healthcare sector, evolving from a tool for streamlining administrative tasks to one influencing essential clinical functions. Understanding how your health system customers are using AI is crucial.
The adoption of AI can standardize care, modify drug utilization patterns, and ultimately shift market share. How Health Systems are Using AI in Clinical Decision-Making is an actionable report that offers insights to help pharmaceutical companies understand and navigate this shift.
The findings are derived from a survey of 25 decision-makers who are leading the deployment of their health systems’ AI initiatives.
What You’ll Learn:
- The new landscape of AI governance and expertise. A majority of surveyed health systems have established formal AI governing bodies, with significant representation from senior roles.
- How health systems are deploying AI in clinical practice. AI is being used not only for diagnosis, but also in drug selection, and it is being deployed across a range of therapeutic areas.
- The data and guidelines informing clinical AI. Clinical practice guidelines are the most influential source for shaping AI recommendations at health systems.
- How the pharmaceutical industry can collaborate and contribute. A majority of health systems are open to collaboration on AI initiatives. This report identifies the key pillars that will support these partnerships.
By understanding the trends and actions of health systems, pharmaceutical companies can use AI as an important technology driving patient care, medication access, and partnerships.
Want to see more examples, data, and strategies? Download now to access the complete report.
Offered Free by: Precision AQ
See All Resources from: Precision AQ
